<DOC>
	<DOCNO>NCT01031095</DOCNO>
	<brief_summary>The hypothesis : Low dose intracoronary unfractionated heparin effective safe standard dose intravenous unfractionated heparin patient elective percutaneous coronary intervention .</brief_summary>
	<brief_title>( A Novel Pharmacologic Regime Elective Percutaneous Coronary Intervention )</brief_title>
	<detailed_description>Aim : Primary objective : To evaluate efficiency safety low dose intracoronary unfractioned heparin ( UFH ) elective percutaneous coronary intervention ( PCI ) . Secondary objective : - To evaluate effect low dose intracoronary UFH myocardial ischemia PCI . - To evaluate effect low dose intracoronary UFH bleeding complication PCI . - To evaluate cost-effectivity low dose intracoronary UFH elective PCI Study central : - Bursa Postgraduate Hospital , Cardiology Clinic Study population : - plan enrol 200 patient . - Patients randomise two group ( control group:100 patient , study group:100 patient ) Study work : -Write case report form patient - Control inclusion criterion - Demographic data ( age , gender ) - Height , weight , BMI glomerular filtration rate ( GFR ) - Risk factor - laboratory data ( biochemical hematologic ) - Medication history - Echocardiographic data - Angiographic data - Procedure time - PCI data ( vessel diameter , stent diameter , lesion stent length , perform percutaneous transluminal coronary angioplasty ( PTCA ) , etc ) - Before procedure ( activate clotting time ) ACT value - Before procedure troponin I ( TnI ) Creatine kinase MB ( CKMB ) level - Note complication ( MACE , bleeding , hematoma etc ) - Note femoral compression time . 4 week later note first control data . Six month later note second control data .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>The patient ; plan elective PCI write informed consent participation study . The native coronary artery ; lesion narrow &gt; =70 % , lesion without thrombus leave main coronary artery ( LMCA ) lesion chronic total occlusion lesion Patients allergy acetylsalicylic acid ( ASA ) , Clopidogrel heparin Patients perform primary PCI Patients acute coronary syndrome Patients history myocardial infarction ( MI ) two week Patients use UFH low molecular weight heparin ( LMWH ) 24 hour Patients warfarin therapy Patients bleed diathesis , high risk bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>low dose intracoronary heparin</keyword>
</DOC>